Tectonic Therapeutic, Net Worth

Tectonic Therapeutic, Net Worth Breakdown

  TECX
The net worth of Tectonic Therapeutic, is the difference between its total assets and liabilities. Tectonic Therapeutic,'s net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Tectonic Therapeutic,'s assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Tectonic Therapeutic,'s net worth can be used as a measure of its financial health and stability which can help investors to decide if Tectonic Therapeutic, is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Tectonic Therapeutic, stock.

Tectonic Therapeutic, Net Worth Analysis

Tectonic Therapeutic,'s net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Tectonic Therapeutic,'s financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Tectonic Therapeutic,'s overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Tectonic Therapeutic,'s net worth analysis. One common approach is to calculate Tectonic Therapeutic,'s market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Tectonic Therapeutic,'s stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Tectonic Therapeutic,'s net worth. This approach calculates the present value of Tectonic Therapeutic,'s future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Tectonic Therapeutic,'s cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Tectonic Therapeutic,'s net worth. This involves comparing Tectonic Therapeutic,'s financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Tectonic Therapeutic,'s net worth relative to its peers.

Enterprise Value

34.07 Million

To determine if Tectonic Therapeutic, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tectonic Therapeutic,'s net worth research are outlined below:
Tectonic Therapeutic, appears to be risky and price may revert if volatility continues
Tectonic Therapeutic, was previously known as AVROBIO and was traded on NASDAQ Exchange under the symbol AVRO.
Net Loss for the year was (42.82 M) with profit before overhead, payroll, taxes, and interest of 0.
Tectonic Therapeutic, generates negative cash flow from operations
Tectonic Therapeutic, has a frail financial position based on the latest SEC disclosures
About 39.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Marc Schwabish of 2000 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3

Follow Tectonic Therapeutic,'s market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 265.07 M.

Market Cap

57.27 Million

Project Tectonic Therapeutic,'s profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.42)(0.44)
Return On Capital Employed(0.47)(0.49)
Return On Assets(0.42)(0.44)
Return On Equity(0.45)(0.47)
When accessing Tectonic Therapeutic,'s net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Tectonic Therapeutic,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Tectonic Therapeutic,'s profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Tectonic Therapeutic,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tectonic Therapeutic,. Check Tectonic Therapeutic,'s Beneish M Score to see the likelihood of Tectonic Therapeutic,'s management manipulating its earnings.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tectonic Therapeutic, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tectonic Therapeutic,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tectonic Therapeutic, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tectonic Therapeutic, time-series forecasting models is one of many Tectonic Therapeutic,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tectonic Therapeutic,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Tectonic Therapeutic, Earnings per Share Projection vs Actual

Tectonic Therapeutic, Corporate Management

Daniel MBAChief OfficerProfile
MS MDChief OfficerProfile
Christian CortisExecutive OfficerProfile
Peter McNamaraChief OfficerProfile
Anthony MDChief OfficerProfile
John DienerSenior SciencesProfile
Marc SchwabishChief OfficerProfile

Additional Tools for Tectonic Stock Analysis

When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.